Study of GLS-010 Injection in Patients With Recurrent or Metastatic Cervical Cancer

NCT03972722 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

89

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: GLS-010

Sponsor

Guangzhou Gloria Biosciences Co., Ltd.